The arrival of new drugs to treat Alzheimer's disease will mean a change in the status of the illness, posing a considerable challenge to all those responsible for the care of these patients. This pocketbook illustrates the scientific, clinical and economic impact of these drugs. Based on available literature, it presents a clear introduction to cholinesterase inhibitors. The intention of the pocketbook is to facilitate good pharmacological management of all Alzheimer's disease patients, enabling doctors to make the most informed decision in all possible cases.
Sprache
Verlagsort
Zielgruppe
Für höhere Schule und Studium
Für Beruf und Forschung
ISBN-13
978-1-85317-911-2 (9781853179112)
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Klassifikation
Structure and classes of cholinesterases; cholinesterase inhibitors - how do they act on the brain?; why are we treating Alzheimer's patients with cholinesterase inhibitors?; dosage, brain inhibition and clinical efficacy.
